Clinical Trial Update: FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer [Phase 2]

View source ↗

Summary

An NCI-sponsored Phase 2 study evaluated FDG and FMISO PET imaging to assess tumor hypoxia in cervical cancer; the trial has completed and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Cancer
• Cervical Squamous Cell Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-06-26